Company ProfilePremium

Sysmex Corporation

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Sysmex Corporation - Healthcare showcase

Year Founded & Workforce

1968

8,715 Employees

Industry

Healthcare

Services

Immunoassay SystemImmunoassays
S

Sysmex Corporation Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Sysmex Corporation Overview

Company Headquarters: Kobe, Japan

Founded: 1968

Workforce: ~ 8,715

Company Working: Sysmex Corporation (Sysmex) develops, manufactures, sells, and exports/imports diagnostic instruments, reagents, and related software. The company provides products, services, and support to customers in more than 190 countries. Its key customers include national and other public hospitals, private hospitals, universities, research institutes, other medical institutions. Sysmex operates in the domain of healthcare testing, which involves examining blood, urine, and other samples. The company's business is in the domain of in vitro diagnostics (IVD), which is essential to the diagnosis and treatment of diseases. The company operates through various subsidiaries in different parts of the world, including the Americas, EMEA, and Asia-Pacific.

Strategy

Sysmex Corporation is focused on launching clinical flow cytometry (FCM) products, owing to the increasing demand for flow cytometry systems, globally. Additionally, the company is aiming to increase its life science business by entering the clinical PCR market. Also, Sysmex Corporation is focusing on increasing its business in the immunology and in-vitro diagnostic segment. It plans to promote scientific support activities to increase the level of IVD testing in Asia-Pacific.

Company Snapshot

$2,690M

Revenue

8,715

Employees

1968

Founded

Kobe, Japan

Headquarters

SWOT Analysis

Strengths

  • Company has presence in EMEA, Asia-Pacific, the Americas, and Japan
  • Major player in the hematology field
  • Increase in sales to second-tier and lower hospitals in China

Weaknesses

  • Limited product range compared to major players
  • Lawsuits

Opportunities

  • Investing in new life science fields
  • Expanding business in the hepatic disease domain

Threats

  • Fluctuating exchange rates
  • Excise duty on immunoassay systems

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • Sysmex Corporation
    • Immunoassay System
    • Immunoassays

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Global Sales fell from USD 2,690 Mn in 2019 to USD 2,650 Mn in 2021.
Sysmex Corporation — By Business Segment
Series (USD Mn)201920202021
Global Sales2,6902,9202,650
R&D Expenditure180210200

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.